Autopsy report · NCT03973853

How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia

“Decision to stop the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Hôpital le Vinatier

Sponsor type

University, hospital or other

Conditions

Schizophrenia

Interventions

Virtual reality driving stimulation program; TAU

Participants

0

Sites

2

Countries

France

Trials that died the same way

• A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
  “Business decision to stop the study.” (91% match in meaning)
• Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients with Chronic Pain
  “Sponsor decision to stop the study” (82% match in meaning)
• Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
  “Study stopped following management decision” (82% match in meaning)
• Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients with OA
  “Investigator decision to withdraw study.” (80% match in meaning)
• Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
  “Company decision to halt study” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.